A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Pain; Bone Neoplasms; Neoplasm Metastasis
Interventions: DRUG: ibandronate [Bondronat]
Sponsor: Hoffmann-La Roche